Arcadia Biosciences (RKDA)
(Delayed Data from NSDQ)
$4.21 USD
-0.09 (-2.09%)
Updated Aug 1, 2025 12:55 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
RKDA 4.21 -0.09(-2.09%)
Will RKDA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RKDA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RKDA
Arcadia Biosciences to Merge With Roosevelt, Shares Surge 105%
Arcadia Biosciences' Q3 Earnings Miss Estimates, Sales Increase Y/Y
RKDA: What are Zacks experts saying now?
Zacks Private Portfolio Services
GrowGeneration Earnings Miss Estimates in Q3, Revenues Dip Y/Y
Arcadia Biosciences (RKDA) Reports Q3 Loss, Tops Revenue Estimates
Hydrofarm Holdings Group, Inc. (HYFM) Reports Q3 Loss, Lags Revenue Estimates
Other News for RKDA
Arcadia Biosciences Faces Payment Default from Above Food
Arcadia Biosciences, Inc. (RKDA) Q1 2025 Earnings Call Transcript
Arcadia Biosciences Reports Strong Q1 2025 Results
Arcadia Biosciences (RKDA) Gets a Buy from Lake Street
Arcadia Biosciences Reports Strong Growth Amid Challenges